Quick Takeaways
- Chris Nolet has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $11,383.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Chris Nolet
- Location
- Newark, CA
- Summary
- The estimated net worth of Chris Nolet is at least $11,383 dollars as of 03 Jul 2025. Chris Nolet is the Director of POLARITYTE, INC. and owns shares of POLARITYTE, INC. stock worth about $11.4K.
- Signature
- By: /s/ Herb Cross, as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Chris Nolet and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: POLARITYTE, INC. ($11,383).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Chris Nolet
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| PTE | POLARITYTE, INC. | Director | $11,383 | 12 Jan 2023 | ||
| RVNC | Revance Therapeutics, Inc. | Director | $0 | 04 Feb 2025 | ||
| AVBP | ArriVent BioPharma, Inc. | Director | 18 Jun 2025 | |||
| JSPR, JSPRW | Jasper Therapeutics, Inc. | Director | 03 Jul 2025 |
Insider Transactions Reported by Chris Nolet:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.